Combination therapy in hormone-refractory prostate cancer

被引：0
|
作者：
Daniel P. Petrylak
机构：
来源：
Current Oncology Reports | 2001年 / 3卷 / 5期
关键词：
Prostate Cancer; Hydrocortisone; Docetaxel; Mitoxantrone; Estramustine;
D O I：
10.1007/s11912-001-0033-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：453 / 453
相关论文
共 50 条
  • [1] Therapy of hormone-refractory prostate cancer
    Heidenreich, A
    UROLOGE, 2005, 44 (12): : 1481 - 1494
  • [2] Therapy of hormone-refractory prostate cancer
    不详
    ANTICANCER RESEARCH, 2005, 25 (6D) : 4796 - 4796
  • [3] Which drug combination for hormone-refractory prostate cancer
    Doggrell, SA
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (04) : 667 - 670
  • [4] Hormone-Refractory prostate cancer
    Rini B.I.
    Small E.J.
    Current Treatment Options in Oncology, 2002, 3 (5) : 437 - 446
  • [5] Hormone-refractory prostate cancer
    Alexandre, I.
    Rixe, O.
    ANNALES D UROLOGIE, 2007, 41 (02) : 47 - 55
  • [6] Targeted therapy in hormone-refractory prostate cancer (HPRC)
    Sternberg, C. N.
    ANNALS OF ONCOLOGY, 2007, 18 : 21 - 21
  • [7] Molecular triggered therapy in hormone-refractory prostate cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 93 - 93
  • [8] Antiandrogen and vaccine therapy for hormone-refractory prostate cancer
    Alexandra King
    Nature Clinical Practice Oncology, 2005, 2 (11): : 541 - 542
  • [9] Antiandrogen and vaccine therapy for hormone-refractory prostate cancer
    Alexandra King
    Nature Clinical Practice Urology, 2005, 2 (11): : 524 - 525
  • [10] Combination of epirubicin and cisplatin in hormone-refractory metastatic prostate cancer
    Huan, SD
    Stewart, DJ
    Aitken, SE
    Segal, R
    Yau, JC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (05): : 471 - 474
12345